At Veracyte, we are committed to transforming patient care through innovative molecular diagnostics that deliver precise and clinically actionable insights. Founded in 2008, we pioneered the Afirma Genomic Sequencing Classifier technology, which established a new field known as molecular cytology. Our technology enables physicians to make more informed diagnostic and treatment decisions, ultimately improving patient outcomes and reducing unnecessary healthcare costs.
Our origins trace back to the groundbreaking work of Dr. Brett Circe and Dr. Tom Weis, whose scientific vision set the foundation for our mission. We combine cutting-edge genomic science with advanced bioinformatics to provide physicians with accurate diagnostic tools across various medical specialties.
Headquartered in South San Francisco, we are proud to serve the global medical community by translating complex genomic data into clear clinical answers. Our dedicated leadership team, including our co-founder and Executive Chairwoman Bonnie H. Anderson and CEO Marc A. Stapley, drives our growth and innovation forward.
We continuously invest in research and development to expand our portfolio of diagnostic tests, aiming to address unmet clinical needs in oncology, pulmonology, endocrinology, and other fields. Our ultimate goal is to empower healthcare providers with information that enhances patient care pathways, reduces uncertainty, and optimizes treatment strategies.
By focusing on molecular diagnostics, we strive to make a meaningful impact on healthcare systems worldwide, improving quality of life for patients through precision medicine and personalized treatment approaches. Veracyte stands at the forefront of genomic diagnostics, committed to shaping the future of medicine with science, technology, and patient-centric innovation.
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees to not only make a meaningful impact on the lives of patients, but to also learn and grow within a purpose driven environment. This is what we call the Veracyte way – it’s about how we work together, guided by our values, to give clinicians the insights they need to help patients make life-changing decisions.
Our Values:
- We Seek A Better Way: We innovate boldly, learn from our setbacks, and are resilient in our pursuit to transform cancer care
- We Make It Happen: We act with urgency, commit to quality, and bring fun to our hard work
- We Are Stronger Together: We collaborate openly, seek to understand, and celebrate our wins
- We Care Deeply: We embrace our differences, do the right thing, and encourage each other
What We Can Offer You
Veracyte is a growing company that offers significant career opportunities if you are curious, driven, patient-oriented and aspire to help us build a great company. We offer competitive compensation and benefits, and are committed to fostering an inclusive workforce, where diverse backgrounds are represented, engaged, and empowered to drive innovative ideas and decisions. We are thrilled to be recognized as a 2024 Certified™ Great Place to Work® in both the US and Israel – a testament to our dynamic, inclusive, and inspiring workplace where passion meets purpose.
Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. For more information, please visit www.veracyte.com and follow the company on X (Formerly Twitter).
Veracyte, Inc. is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status or disability status. Veracyte participates in E-Verify in the United States. View our CCPA Disclosure Notice.
If you receive any suspicious alerts or communications through LinkedIn or other online job sites for any position at Veracyte, please exercise caution and promptly report any concerns to [email protected]
Report this company